[Skin, a privileged target for gene therapy]

Area of Science:

• Dermatology
• Molecular Biology
• Gene Therapy

Background:

• Gene therapy targets skin cells (keratinocytes, fibroblasts, tumor cells) via direct in vivo or ex vivo (in vitro) methods.
• In vivo gene transfer requires precise targeting to skin cells, avoiding systemic spread.
• In vitro methods involve culturing harvested skin cells for therapeutic applications, similar to established skin grafting.

Discussion:

• Viral vectors (retroviruses, adenoviruses) and physicochemical methods are explored for gene delivery.
• Gene therapy holds potential for genodermatoses, localized/systemic therapeutic factor expression, and engineered skin cancer cells.
• Challenges include efficient and safe gene transfer to specific skin cell populations.

Key Insights:

• Cultured keratinocytes and fibroblasts are promising for producing therapeutic proteins with local or systemic effects.
• Gene therapy can address genetic skin disorders and enhance cancer treatment.
• Developing safe and effective gene delivery systems is crucial for clinical translation.

Outlook:

• The most immediate advancements in skin gene therapy are expected from using keratinocytes and fibroblasts for protein production.
• Further research into non-viral vectors and improved in vivo targeting will enhance therapeutic efficacy.
• Gene therapy integration into standard dermatological practice is anticipated for treating a range of skin conditions.